Few sectors combine strong growth potential, value, and income like healthcare. Built on innovation and steady demand, the sector has long powered portfolios with unique investor benefits. Successful firms like our latest Best Dividend Capture Pick have delivered vast returns and dividends.
You can check out the Best Dividend Capture Stocks List to explore all the stocks.
The healthcare sector encompasses diverse sub-sectors and markets. Our pick operates in pharmaceuticals and ranks among the world’s largest firms, with numerous past and current blockbusters in its pipeline and on the market. These drugs generate substantial cash flow, creating a flywheel effect that funds innovation, M&A, and more therapies while boosting shareholder rewards for decades.
Our pick has returned to serious growth.
This includes expansion into obesity and weight-control medications. The GLP-1 drug market continues to grow, not only in reimbursement systems but also among consumers willing to pay out of pocket. With partnerships and buyouts, our pick holds strong growth potential. Meanwhile, the firm advances cancer meds in late-stage trials and uses AI and data science to shorten lead times for new therapies and drug development.
All this enhances our pharmaceutical pick’s potential as a significant dividend winner.
With strong growth and a long history of dividend increases, our pick serves as an excellent dividend capture play. This strategy entails buying a stock before its ex-dividend date and selling after recovering the payout. With an ex-dividend date of Friday, January 23, and a historical recovery averaging 6.4 days, our pick suits this approach well.
Investors seeking total return from income and capital appreciation will find our latest biopharmaceutical pick a lucrative option.
